Arvinas (ARVN) EBITDA Margin (2017 - 2026)
Arvinas (ARVN) reported EBITDA Margin of -11700.00% for Q3 2026, down 11598.33 percentage points from -101.67% a year earlier and down 11767.28 percentage points from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) EBITDA Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Arvinas' EBITDA Margin came in at -9.81%, up 20.16 percentage points year-over-year; for FY2025, it came in at -42.35%, up 49.15 percentage points from FY2024.
- EBITDA Margin has a five-year change of +411.71 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -91.50% in FY2024 (+412.20 pp), -503.69% in FY2023 (-309.55 pp), -194.14% in FY2022 (+147.65 pp) and -341.79% in FY2021 (+112.26 pp).
- The Q3 2026 figure ranks as the lowest quarterly EBITDA Margin in data going back to Q3 2017.
- Year over year, EBITDA Margin gained in two of the last seven quarters, with an average year-over-year change of -1753.90 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2022 (a gain of 733.06 percentage points); the low point was Q3 2026 (a drop of 11598.33 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 67.28% (Q2 2026), -402.56% (Q1 2026) and -775.79% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | -11,700.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11,700.00% |
| Jun 30, 2026 | 67.28% |
| Mar 31, 2026 | -402.56% |
| Dec 31, 2025 | -775.79% |
| Sep 30, 2025 | -101.67% |
| Jun 30, 2025 | -313.84% |
| Mar 31, 2025 | 39.94% |
| Dec 31, 2024 | -94.76% |
| Sep 30, 2024 | -55.96% |
| Jun 30, 2024 | -60.13% |
| Mar 31, 2024 | -322.92% |
| Sep 30, 2023 | -208.67% |
| Jun 30, 2023 | -133.03% |
| Mar 31, 2023 | -264.31% |
| Dec 31, 2022 | -194.18% |
| Sep 30, 2022 | -187.35% |
| Jun 30, 2022 | -188.76% |
| Mar 31, 2022 | -210.94% |
| Dec 31, 2021 | -138.25% |
| Sep 30, 2021 | -494.62% |
API Access
Arvinas EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();